SCHEMBL28169784

SCHEMBL28169784

c1ccc(CN2CCC(CN3CCCC3)CC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 1/20 0.67
ACHE P22303 2/20 0.59
ALDH1A1 P00352 2/20 0.58
CXCR4 P61073 1/20 0.58
SIGMAR1 Q99720 4/20 0.57
HTR1A P08908 1/20 0.57
MEN1 O00255 1/20 0.55
TSHR P16473 1/20 0.55
KMT2A Q03164 1/20 0.55
DRD2 P14416 2/20 0.54
DRD4 P21917 1/20 0.54
DRD3 P35462 1/20 0.54
KDM4E B2RXH2 1/20 0.54
GLA P06280 1/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
HTT P42858 1/20 0.54
ATM Q13315 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
HTR2A P28223 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8176746 0.86 SIGMAR1 (0.62) CCR3ACHESIGMAR1HTR1AGAA
SCHEMBL2796077 0.85 MC4R (0.72) CCR3ACHEALDH1A1CXCR4SIGMAR1
SCHEMBL23270011 0.85 SIGMAR1 (0.72) CCR3ACHEALDH1A1CXCR4SIGMAR1
SCHEMBL13952 0.83 SIGMAR1 (0.81) ACHEALDH1A1SIGMAR1DRD4KDM4E
SCHEMBL1777747 0.83 SIGMAR1 (0.81) ACHEALDH1A1SIGMAR1DRD4KDM4E
Hydrochloric Acid SCHEMBL9633667 0.82 ACHE (0.64) CCR3ACHEALDH1A1CXCR4SIGMAR1
SCHEMBL29260004 0.82 CCR3 (0.61) CCR3ACHEALDH1A1CXCR4SIGMAR1
SCHEMBL2791000 0.82 CCR3 (0.56) CCR3ACHEALDH1A1CXCR4SIGMAR1
SCHEMBL23384237 0.82 HRH3 (0.59) CCR3ACHEALDH1A1CXCR4SIGMAR1
Ammonia Solution, Strong SCHEMBL3699405 0.81 SIGMAR1 (0.77) ACHEALDH1A1SIGMAR1DRD4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107001318-A N- (hetero) aryl-substituted heterocyclic derivatives useful for the treatment of diseases or disorders associated with the central nervous system 克罗诺斯治疗有限公司 2017-08-01 CN disclosed